EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

Statin-induced immune-mediated necrotizing myopathy with concomitant increase of anti-HMGCR and anti-ACHR antibodies

Razmig Garabet iD, Sanjeev Herr, Nicole Griffin, Kuruganti Reddy

Rheumatology International · 2024

DOI: 10.1007/s00296-024-05559-8 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Rheumatology International, 2024. Verfasst von Razmig Garabet und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical Student, Drexel University College of Medicine, Philadelphia, PA, USA. rtg39@drexel.edu. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Muscular Diseases, Myositis, Autoimmune Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Statin-induced immune-mediated necrotizing myopathy (IMNM) is a rare systemic neuromuscular condition. We present a case of a patient with a severe phenotype of the disease that was found to have an increase in anti-HMGCR and anti-ACHR antibodies. A potential association between these antibodies have not been previously described. A 67-year-old male with hyperlipidemia, who was recently initiated on atorvastatin therapy, presented to the ED with progressive muscle weakness. Within a few days of admission, the patient developed complete flaccid paralysis and respiratory distress requiring intubation. The patient's CK was elevated to 24,000 and there was an increase of anti-HMGCR and anti-ACHR antibodies. Impressions from MRI and thigh biopsy solidified a diagnosis of statin-induced IMNM. The patient was treated with methylprednisolone, IVIG, and rituximab, which provided resolution of symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsMuscular DiseasesMyositisAutoimmune DiseasesMaleHumansAgedAutoantibodies

Stichwörter der Autor:innen

Anti-ACHRAnti-HMGCRCase reportNeuromuscularStatin-induced immune-mediated necrotizing myopathy

Substanzen

Hydroxymethylglutaryl-CoA Reductase InhibitorsAutoantibodies

Autor:innen und Institutionen

  • Medical Student, Drexel University College of Medicine, Philadelphia, PA, USA. rtg39@drexel.edu.
  • Medical Student, Drexel University College of Medicine, Philadelphia, PA, USA.
  • Department of Rheumatology, Kaiser Permanente Northern California, Walnut Creek, CA, USA.
  • Department of Pulmonary Medicine, Kaiser Permanente Northern California, Walnut Creek, CA, USA.

ORCID-Profile: Razmig Garabet

Zitieren

APA

Garabet, R., Herr, S., Griffin, N., & Reddy, K. (2024). Statin-induced immune-mediated necrotizing myopathy with concomitant increase of anti-HMGCR and anti-ACHR antibodies. Rheumatology International. https://doi.org/10.1007/s00296-024-05559-8

Vancouver

Garabet R, Herr S, Griffin N, Reddy K. Statin-induced immune-mediated necrotizing myopathy with concomitant increase of anti-HMGCR and anti-ACHR antibodies. Rheumatology International. 2024. doi:10.1007/s00296-024-05559-8

BibTeX
@article{Garabet2024,
  author = {Garabet, Razmig and Herr, Sanjeev and Griffin, Nicole and Reddy, Kuruganti},
  title = {Statin-induced immune-mediated necrotizing myopathy with concomitant increase of anti-HMGCR and anti-ACHR antibodies},
  journal = {Rheumatology International},
  year = {2024},
  doi = {10.1007/s00296-024-05559-8}
}
Kostenlos starten →